MX2022002154A - Modulacion de las respuestas de celulas t por ul18 del citomegalovirus humano. - Google Patents
Modulacion de las respuestas de celulas t por ul18 del citomegalovirus humano.Info
- Publication number
- MX2022002154A MX2022002154A MX2022002154A MX2022002154A MX2022002154A MX 2022002154 A MX2022002154 A MX 2022002154A MX 2022002154 A MX2022002154 A MX 2022002154A MX 2022002154 A MX2022002154 A MX 2022002154A MX 2022002154 A MX2022002154 A MX 2022002154A
- Authority
- MX
- Mexico
- Prior art keywords
- cell responses
- human cytomegalovirus
- modulation
- mhc
- methods
- Prior art date
Links
- 241000701024 Human betaherpesvirus 5 Species 0.000 title abstract 2
- 230000005867 T cell response Effects 0.000 title abstract 2
- 210000001266 CD8-positive T-lymphocyte Anatomy 0.000 abstract 1
- 101100048372 Human cytomegalovirus (strain AD169) H301 gene Proteins 0.000 abstract 1
- 101100048373 Human cytomegalovirus (strain Merlin) UL18 gene Proteins 0.000 abstract 1
- 101150037769 TRX2 gene Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/464838—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2833—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
- C12N5/0638—Cytotoxic T lymphocytes [CTL] or lymphokine activated killer cells [LAK]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
- C12N2710/16141—Use of virus, viral particle or viral elements as a vector
- C12N2710/16143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Plant Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La revelación se refiere a métodos de modulación de respuestas de células T por UL18 de citomegalovirus humano. La revelación también se refiere a métodos para generar células T CD8+ restringidas por MHC-Ia, MHC-II y/o MHC-E.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962889310P | 2019-08-20 | 2019-08-20 | |
PCT/US2020/047050 WO2021034964A1 (en) | 2019-08-20 | 2020-08-19 | Modulation of t cell responses by ul18 of human cytomegalovirus |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2022002154A true MX2022002154A (es) | 2022-03-17 |
Family
ID=74660048
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2022002154A MX2022002154A (es) | 2019-08-20 | 2020-08-19 | Modulacion de las respuestas de celulas t por ul18 del citomegalovirus humano. |
Country Status (17)
Country | Link |
---|---|
US (1) | US20220307054A1 (es) |
EP (1) | EP4017985A4 (es) |
JP (1) | JP2022544704A (es) |
KR (1) | KR20220047619A (es) |
CN (1) | CN114402080A (es) |
AU (1) | AU2020334061A1 (es) |
BR (1) | BR112022003159A2 (es) |
CA (1) | CA3148642A1 (es) |
CL (1) | CL2022000398A1 (es) |
CO (1) | CO2022002922A2 (es) |
CR (1) | CR20220093A (es) |
DO (1) | DOP2022000041A (es) |
EC (1) | ECSP22013145A (es) |
IL (1) | IL290748A (es) |
MX (1) | MX2022002154A (es) |
PE (1) | PE20220648A1 (es) |
WO (1) | WO2021034964A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023034801A1 (en) * | 2021-08-31 | 2023-03-09 | Vir Biotechnology, Inc. | Recombinant hcmv vectors and uses thereof |
WO2024059635A2 (en) * | 2022-09-13 | 2024-03-21 | Oregon Health And Science University | Universal t cell-based, cmv-vectored vaccine for influenza |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1410314A (en) | 1920-11-04 | 1922-03-21 | Edgar B Hyatt | Garage-door control |
US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
US20020069244A1 (en) | 1999-11-24 | 2002-06-06 | John Blair | Message delivery system billing method and apparatus |
EP1364037A4 (en) * | 2001-02-02 | 2005-08-03 | Chemocentryx Inc | METHODS AND COMPOSITIONS USEFUL IN STIMULATING AN IMMUNE RESPONSE |
US8289976B2 (en) | 2006-09-28 | 2012-10-16 | Packetfront Network Products Ab | Method for automatically providing a customer equipment with the correct service |
DE112013006773T5 (de) | 2013-03-06 | 2015-12-10 | SiEVA | Vorrichtung für high-side Transistor-Brückentreiber |
WO2016049022A1 (en) * | 2014-09-23 | 2016-03-31 | Board Of Trustees Of Michigan State University | Compositions and methods for modulating an immune response |
EP3256595A4 (en) * | 2015-02-10 | 2018-09-26 | Oregon Health & Science University | Methods and compositions useful in generating non canonical cd8+ t cell responses |
CN116926128A (zh) | 2015-11-20 | 2023-10-24 | 俄勒冈健康与科学大学 | 包含微小rna识别元件的cmv载体 |
WO2017223146A1 (en) * | 2016-06-22 | 2017-12-28 | Aeras | Recombinant cytomegalovirus vectors as vaccines for tuberculosis |
BR112019007982A2 (pt) | 2016-10-18 | 2019-07-02 | Univ Oregon Health & Science | vetores de citomegalovírus elicitando células t restringidas por moléculas do complexo de histocompatibilidade e principal |
-
2020
- 2020-08-19 MX MX2022002154A patent/MX2022002154A/es unknown
- 2020-08-19 US US17/636,506 patent/US20220307054A1/en active Pending
- 2020-08-19 CA CA3148642A patent/CA3148642A1/en active Pending
- 2020-08-19 JP JP2022511223A patent/JP2022544704A/ja active Pending
- 2020-08-19 BR BR112022003159A patent/BR112022003159A2/pt unknown
- 2020-08-19 CR CR20220093A patent/CR20220093A/es unknown
- 2020-08-19 KR KR1020227008642A patent/KR20220047619A/ko unknown
- 2020-08-19 AU AU2020334061A patent/AU2020334061A1/en active Pending
- 2020-08-19 PE PE2022000281A patent/PE20220648A1/es unknown
- 2020-08-19 CN CN202080064753.2A patent/CN114402080A/zh active Pending
- 2020-08-19 EP EP20855077.2A patent/EP4017985A4/en active Pending
- 2020-08-19 WO PCT/US2020/047050 patent/WO2021034964A1/en unknown
-
2022
- 2022-02-18 CL CL2022000398A patent/CL2022000398A1/es unknown
- 2022-02-18 EC ECSENADI202213145A patent/ECSP22013145A/es unknown
- 2022-02-18 DO DO2022000041A patent/DOP2022000041A/es unknown
- 2022-02-20 IL IL290748A patent/IL290748A/en unknown
- 2022-03-14 CO CONC2022/0002922A patent/CO2022002922A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
CO2022002922A2 (es) | 2022-04-19 |
CA3148642A1 (en) | 2021-02-25 |
EP4017985A4 (en) | 2023-09-27 |
DOP2022000041A (es) | 2022-08-15 |
PE20220648A1 (es) | 2022-04-28 |
WO2021034964A1 (en) | 2021-02-25 |
JP2022544704A (ja) | 2022-10-20 |
IL290748A (en) | 2022-04-01 |
CN114402080A (zh) | 2022-04-26 |
CL2022000398A1 (es) | 2023-03-17 |
KR20220047619A (ko) | 2022-04-18 |
CR20220093A (es) | 2022-06-15 |
US20220307054A1 (en) | 2022-09-29 |
BR112022003159A2 (pt) | 2022-05-17 |
ECSP22013145A (es) | 2022-04-29 |
AU2020334061A1 (en) | 2022-03-10 |
EP4017985A1 (en) | 2022-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2017066561A3 (en) | Regulatory t cell pd-1 modulation for regulating t cell effector immune responses | |
CL2022000398A1 (es) | Modulación de las respuestas de células t por ul18 del citomegalovirus humano | |
AU2018289493A1 (en) | Methods for modulating regulatory T cells, regulatory B cells, and immune responses using modulators of the APRIL-TACI interaction | |
MX2020002530A (es) | Indicacion de haces para control de potencia de enlace ascendente. | |
AU2017346788A8 (en) | Cytomegalovirus vectors eliciting T cells restricted by major histocompatibility complex E molecules | |
MX2020006688A (es) | Celulas presentadoras de antigenos artificiales y metodos de uso. | |
EP4340251A3 (en) | Group-based beam management | |
WO2019140327A3 (en) | Display lighting systems with circadian effects | |
MX2020007812A (es) | Moduladores del receptor de quimiocina y usos de los mismos. | |
MX2020005503A (es) | Metodos para activar, modificar y expandir linfocitos t gamma delta para el tratamiento del cancer y de neoplasias malignas relacionadas. | |
MX2019001223A (es) | Moduladores de receptores de quimioquina y usos de los mismos. | |
WO2018175408A8 (en) | METHODS AND COMPOSITIONS FOR MODULATION OF IMMUNE CELLS | |
MY180771A (en) | System and method for beam-based physical random-access | |
MX2014008397A (es) | Refractometro con un generador de frente de onda remoto. | |
PH12020551144A1 (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
MX2020008106A (es) | Moduladores del receptor nmda espiro-lactama y usos de los mismos. | |
MX2009008918A (es) | Activacion de celulas que presentan antigeno humano a traves de clec-6. | |
MX2020001833A (es) | Moduladores de piruvato quinasas y uso de los mismos. | |
MY191776A (en) | Method for preparing electrocompetent yeast cells, and method for using said cells | |
PH12020550217A1 (en) | Nutrient-spore formulations and uses thereof | |
WO2015035063A3 (en) | MODULATION OF γδT CELLS | |
MX2017008141A (es) | Dispositivo del lado de la red, ue y metodo de ajuste de potencia. | |
AU2017254665A1 (en) | Compositions and methods for enhanced gene expression of pklr | |
MX2021002702A (es) | Metodos para expandir celulas t del receptor de antigeno quimerico especificas de antigenos, composiciones y usos relacionados con las mismas. | |
IN2014KN01525A (es) |